Lanleys Biotechnologies Laboratory (LBL) is an innovative research-based biotech company located in The Biotech City of Laval, Québec, Canada.
We offer high quality tag and loading control mouse monoclonal antibodies for western blotting (WB) and customized antibody production services to research labs worldwide.
The quality of our antibodies is guaranteed as they are all generated and manufactured in-house. Moreover, our services are cost-effective, reliable and flexible.
With a well-established technology platform, LBL is also active in the early development of monoclonal antibody drugs. Our current R&D pipeline consists of several proprietary antibody products, which have pharmaceutical potentials in cancer and immune diseases. These antibodies are uniquely designed by LBL scientists, and can be used to develop diagnostic kits and/or refined for therapeutic treatment.
LBL is looking for partners for out-licensing our existing pharmaceutical antibodies and research collaboration to expedite pre-clinical plans.